A pharmacy is where one can get prescription medications. It may be located inside a grocery shop, drugstore, chemist, or other establishment. Drug store refers to a location whose major activity is the selling of pharmaceuticals, medicines, and pharmaceutical preparations. Drug stores have a regular prescription department and hire a registered pharmacist on-site at all times. The main drug types of pharmacies and drug stores are prescription drugs and over-the-counter drugs. Prescription drugs refer to a drug that can be obtained only with a physician's prescription. The various types involved are community pharmacy, hospital pharmacy, clinical pharmacy, industrial pharmacy, compounding pharmacy, consulting pharmacy, ambulatory care pharmacy, regulatory pharmacy, and homecare pharmacy. The different product types included are skincare, cold and flu, dental, weight loss, vitamins, and other product types. The pharmacies and drug stores market research report is one of a series of new reports from The Business Research Company that provides pharmacies and drug stores market statistics, including pharmacies and drug stores industry global market size, regional shares, competitors with a pharmacies and drug stores market share, detailed pharmacies and drug stores market segments, market trends and opportunities, and any further data you may need to thrive in the pharmacies and drug stores industry. This pharmacies and drug stores market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global pharmacies and drug stores market size will grow from $1,126.63 billion in 2022 to $1,205.81 billion in 2023 at a compound annual growth rate (CAGR) of 7.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global pharmacies and drug stores market size is expected to grow to $1,513.65 billion in 2027 at a CAGR of 5.8%. The growing ageing population and increasing health consciousness among the global populace are likely to drive the pharmacy and drug store market. The geriatric population is more vulnerable to acquiring several diseases that increase their dependence on pharmacies and drug stores, thus indirectly affecting the market. According to the Global Health and Aging report, the number of people aged 65 or older is projected to grow to nearly 1.5 billion in 2050, with most of the increase in developing countries. Certain health conditions are expected to be a challenge to our health care system with the increasing ageing population. These conditions include cancer, dementia, an increase in the number of falls, obesity, and diabetes. Due to the increasing aging population, the number of cases is expected to increase, thus providing a growing customer base for pharmacies and drug stores. Rapidly increasing cost pressures from regulatory agencies and payers will restrain the pharmacies and drug stores market. Government budgetary pressures are leading to lower pharmacy compensation for most countries with public health care. The consolidation of pharmacy benefit management firms in the U.S. has worked similarly, driving lower costs and margins, and shifting prescription volumes to the delivery of direct or mail orders. Governments would be the largest healthcare payers in virtually every country. This, in turn, creates increased pressure on taxpayers and government spending, with consequent pharmaceutical effects. These factors are expected to have a negative impact on the pharmacies and drug stores market as they increase cost pressures from regulatory agencies and affect the market’s growth. Working long hours and drive-through locations are the major factors contributing to increasing the pharmacy and drugstore market growth. As competition has increased from mass merchandisers and supermarkets, as well as from direct mail prescription services, drug stores have been adding value in the form of 24-hour operations and drive-through pharmacies. The US Pharmacy Study measures customer satisfaction with their pharmacy experience across major chain drug stores, mass merchandisers, supermarkets, and mail-order pharmacies. The study shows that retail pharmacy businesses continue to shine when it comes to engaging patient-centric services that drive satisfaction. These convenience factors anticipate the growth of pharmacies and the drugstore market. In January 2021, AmerisourceBergen Corporation, a US-based drug wholesale company, acquired Walgreens Boots Alliance, Inc. for the amount of $6.275 billion in cash and 2 million shares of AmerisourceBergen common stock. Acquiring Alliance Healthcare will provide even stronger support for pharmacies and pharmacists across the world and integrate solutions for pharmaceutical manufacturers. Walgreens Boots Alliance, Inc. is a US-based holding company that owns the retail pharmacy chains and manufactures pharmaceuticals and distribution companies. Major players in the pharmacies and drug stores market are Walgreens Boots (WBA), CVS Health (CVS), Rite Aid (RAD), MedPlus, Rexall, Shoppers Drug Mart, Grupo Casa Saba, China Nepstar, AS Watson, and Matsumoto Kiyoshi. Asia-Pacific was the largest region in the pharmacies and drug stores market in 2022. North America was the second-largest region in the global pharmacies and drug stores market. The regions covered in the global pharmacies and drug stores market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the pharmacies and drug stores market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The pharmacies and drug stores market include revenues earned by entities by branded prescription drugs, generic drugs, non-prescription medicines, personal health supplies, and dietary supplements, cosmetics. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global pharmacies and drug stores market is segmented - 1) By Drug Type: Prescription Drugs, OTC drugs 2) By Type: Community Pharmacy, Hospital Pharmacy, Clinical Pharmacy, Industrial Pharmacy, Compounding Pharmacy, Consulting Pharmacy, Ambulatory Care Pharmacy, Regulatory Pharmacy, Home Care Pharmacy 3) By Product Type: Skin Care, Cold and Flu, Dental, Weight Loss, Vitamins, Other Product Types

Medical robots are professional service robots used in and out of hospitals to improve patient care. It is used to assist in medical procedures, develop healthcare technology, and improve overall healthcare. Additionally, medical robotics technology is used in the healthcare industry for surgeries, radiotherapy treatment plans, rehabilitation therapy sessions, and others. The main product types of medical robots are surgical robotics systems, rehabilitation robotics systems, non-invasive radiosurgery systems. Robotic surgery is the use of computer technologies working in conjunction with robot systems to perform medical proceduresIt is applied in laparoscopy, neurosurgery, cardiology, orthopedic surgery, and pharmacy applications that are used in hospitals and clinics, specialty centers, and rehabilitation centers. The medical robotics market research report is one of a series of new reports from The Business Research Company that provides medical robotics market statistics, including the medical robotics industry global market size, regional shares, competitors with a medical robotics market share, detailed medical robotics market segments, market trends and opportunities, and any further data you may need to thrive in the medical robotics industry. This medical robotics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry. The global medical robotics market size grew from $11.14 billion in 2022 to $13.11 billion in 2023 at a compound annual growth rate (CAGR) of 17.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, causing inflation across goods and services and affecting many markets across the globe. The medical robotics market size is expected to grow to $25.47 billion in 2027 at a CAGR of 18.1%. The rising preference for minimally invasive surgery (MIS) is significantly contributing to the growth of the medical robotics market. Minimally invasive surgery refers to surgery that involves a variety of techniques, including applications of medical robots to operate with less damage to the body than with open surgery. There is a rise in minimally invasive surgeries as they are increasingly being preferred by patients due to their lower postoperative pain, postoperative complications, shorter hospital stays, fast recovery times, and others. For instance, results of the research, conducted by Johns Hopkins investigators and published in JAMA Surgery, indicate that American hospitals could collectively prevent thousands of post-surgical complications and save between $280 million and $340 million a year by using more minimally invasive procedures instead of traditional open surgery for routine operations of the appendix, colon, and lungs. Similarly, according to data from the Michigan Surgical Quality Collaborative, robot-assisted procedures accounted for 15.1% of all general surgeries in 2018, up from just 1.8% in 2012. Therefore, the rising preference for minimally invasive surgery drives the medical robotics market. Strategic collaboration between companies is a key trend gaining popularity in the medical robotics market. Companies in the medical robotics industry are undergoing various collaborations to develop new technologies and products. For instance, in February 2022, a US-based advanced photonics company Novanta announced a strategic collaboration with a US-based robotics and AI company MassRobotics to advance innovations in medical and surgical robotics. Novanta’s business units, namely Celera Motion and ATI Industrial Automation, will collaborate with MassRobotics to develop advanced innovations in medical or surgical robotics and improve robotic productivity. In 2020, Medtronics, an American-Irish registered medical device company, acquired Mazor Robotics for $1.64 billion. This acquisition will allow Medtronic to bolster its position in the spine surgery technology area. Through this deal, Medtronics aims to accelerate the advancement and adoption of robotic-assisted surgery in the spine for the benefit of patients, providers, and the healthcare system more broadly. Mazor Robotics is an Israel-based medical company that manufactures robotic guidance systems for various surgeries. Medtronic plc, Titan Medical, Inc., Stryker Corporation, Smith & Nephew plc, ReWalk Robotics, Renishaw PLC., Mazor Robotics, Irobot Corporation, Intuitive Surgical, Hocoma AG, Hansen Medical, Ekso Bionics, Accuracy Inc., Globus Medical, Houston Medical Robotics, Kinova robotics, Kirbey, Kuka Roboter GmbH, and Varian Medical Systems are major players North America will be the largest region in the medical robotics market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical robotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the medical robotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The medical robotics market consists of sales of surgical robots / robot-assisted surgery machine, rehabilitation robots, laboratory robots, hospital robots, social robots. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global medical robotics market is segmented - 1) By Product: Surgical Robotics Systems, Rehabilitation Robotics Systems, Non-invasive Radiosurgery Systems 2) By Application: Laparoscopy, Neurosurgery, Cardiology, Orthopedic Surgery, Pharmacy Applications 3) By End-User: Hospitals And Clinics, Specialty Centers, Rehabilitation Centers

Virtual reality (VR) is an artificial environment created with software that is presented to the user so that the user stops believing and accepts it as a real environment. The main types of components in virtual reality in the healthcare market are hardware and software. The hardware virtual reality in healthcare includes headsets, goggles, and other accessories used in healthcare facilities for medical training, performing virtual surgeries, and other tasks to make the user feel immersed in the 3D environment. The main technologies used in VR in healthcare are full-immersive virtual reality, non-immersive virtual reality, and semi-immersive virtual reality, and it has various device types such as head-mounted displays, gerture-tracking devices, projectors and display units, among others. VR in healthcare is used in research and diagnostics, laboratories, hospitals and clinics, pharmaceutical companies, and others and is applied in patient care management, education and training, fitness management, pharmacy, surgery, and others. The virtual reality in healthcare market research report is one of a series of new reports from The Business Research Company that provides statistics on virtual reality in the healthcare market, including global market size, regional shares, competitors with a virtual reality in healthcare market share, detailed virtual reality in healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the virtual reality in healthcare industry. This virtual reality in healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global virtual reality in healthcare market size grew from $2.07 billion in 2022 to $3.00 billion in 2023 at a compound annual growth rate (CAGR) of 45.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The virtual reality in healthcare market size is expected to grow to $13.76 billion in 2027 at a CAGR of 46.3%. The rise in incidences of neurological disorders is driving the growth of virtual reality in the healthcare market. Neurological disorders are diseases such as Alzheimer’s disease, Parkinson’s disease, dementia, multiple sclerosis, migraines, and others that affect the body’s central nervous system. Immersive VR technology assists in the development of promising applications for the treatment of neurological illnesses. Virtual Reality in Neurology is cost-efficient, patient-friendly, useful for both normal and pathological ageing, and gives ecological validity that standard neuropsychological tests do not provide. For instance, in February 2022, according to the World Health Organization (WHO), a Switzerland-based agency of the United Nations responsible for international public health, epilepsy affects about 50 million individuals worldwide, making it one of the most prevalent neurological conditions worldwide and people with epilepsy make up over 80% of the population in low- and middle-income nations. Therefore, the rise in incidences of neurological disorders is expected to fuel the growth of virtual reality in the healthcare market going forward. Growing technological advancements are shaping virtual reality in the healthcare market. Major companies operating in virtual reality in the healthcare sector are focusing on developing new technological solutions for the healthcare industry to strengthen their position in the market. For instance, in March 2021, the National Health Service (NHS), a UK-based government department, launched a free treatment plan that uses virtual reality technology to help people with trypanophobia conquer their phobias and receive their vaccinations without anxiety. With this plan, patients can train their brains to overcome the fear of needles by engaging in learning exercises and breathing techniques. In January 2020, Teladoc Health, Inc., a US-based virtual healthcare company, acquired InTouch Health for an undisclosed amount. This acquisition enables Teladoc Health to become the first virtual care provider addressing the full range of acuity – from critical to chronic to everyday care – through a single solution across all locations of care globally. InTouch Health is a US-based company that provides virtual reality in healthcare. Major players in the virtual reality in healthcare market are Samsung, Atheer Inc., Augmedix Inc., Firsthand Technology Inc., Microsoft Corporation, Medical Realities Ltd., Mindmaze, Medtronic Inc., Siemens Healthineers, Hologic Inc., Oculus VR, GE Healthcare and Orca Health Inc., North America was the largest region in the virtual reality in healthcare market in 2022. The regions covered in the virtual reality in healthcare market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the Virtual Reality In Healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The virtual reality in the healthcare market includes revenues earned by entities by offering 3D environment to create more impactful visual experiences of space and human anatomy, lowering medical costs, decreasing traumatic events, and improving outcomes. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global virtual reality in healthcare market is segmented - 1) By Component: Hardware, Software 2) By Technology: Full Immersive Virtual Reality, Non-Immersive Virtual Reality, Semi-Immersive Virtual Reality 3) By Device Type: Head-Mounted Display, Gesture-Tracking Device, Projectors and Display Units, Other Devices 4) By Application: Patient Care Management, Education And Training, Fitness Management, Pharmacy, Surgery, Other Applications 5) By End User: Research And Diagnostics, Laboratories, Hospitals And Clinics, Pharmaceutical Companies, Other End Users

mHealth apps are wearable devices and health tracking apps used to monitor and share health information by using mobile technology. mHealth apps include clinical and diagnostic apps, remote monitoring apps, healthy-living apps, clinical reference apps, and productivity apps. These apps are used to monitor and collect community data and clinical data by healthcare providers. The main types of mHealth apps include disease and treatment management, wellness management, and others. The disease and treatment management apps are used to treat the diseases easily through a smartphone and provide primary care from home by using some apps such as mobile MIM radiology app. The wellness management apps are used to provide patient wellness information through mHealth apps. These are divided into connected medical devices which include heart rate meters, wearable fitness sensor devices, blood pressure monitors, pulse oximeters, and others that are used to check body temperatures and insulin levels. mHealth apps are used in various applications such as monitoring services, fitness solutions, diagnostic services, treatment services, and others such as medication tracking, diet, and nutrition. mHealth apps are generally used by physicians, patients, insurance companies, research centers, pharmacies, biopharmaceutical companies, government, tech companies, and others such as telemedicine apps, and administration apps. The mHealth apps market research report is one of a series of new reports from The Business Research Company that provides mHealth apps market statistics, including mhealth apps industry global market size, regional shares, competitors with a mHealth apps market share, detailed mhealth apps market segments, market trends and opportunities, and any further data you may need to thrive in the mHealth apps industry. This mHealth apps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global mhealth apps market size grew from $45.31 billion in 2022 to $56.77 billion in 2023 at a compound annual growth rate (CAGR) of 25.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The mhealth apps market size is expected to grow to $136.64 billion in 2027 at a CAGR of 24.6%. Increasing publicity of mHealth applications due to their increasing benefits to improving patient disease state is expected to propel the growth of the mHealth apps market. Many people are increasingly adapting to the usage of health apps and therefore their popularity is increasing. These apps provide many benefits to monitoring patient disease state. According to Healthcare Information and Management Systems Society, a health app is regularly used by nearly 64% of adults in the United States to measure health metrics. Further, a new study by BMJ in 2021 reported that the Google Play store has nearly 2% of mHealth apps. mHealth apps are being used to improve the treatment and provide information that is easily accessible. Health care professionals are using these health applications for educating the patient and also for self-monitoring. Therefore, the increasing publicity of mHealth applications due to their increasing benefits to improve patient care is driving the growth of the mHealth app market. The adoption of artificial intelligence (AI) and 5G are shaping the mHealth apps market. Artificial intelligence is human intelligence that is processed by machines such as computers and focuses on learning, reasoning, and self-correction and AI is adopting 5G to improve customer experiences. The advancement in artificial intelligence (AI) and 5G has been introducing new opportunities for service providers. Artificial intelligence plays a major role to improve customer service and creating new challenges and even solves network complexities. Companies are launching AI platforms to enhance customer experiences. For example, in January 2020, Babylon Health, a UK-based digital health service provider announced that they are developing an AI-integrated health application to serve 300,000 people in England. In February 2021, Philips, a Netherlands-based health technology company offering mHealth apps based acquired BioTelemetry Inc. for an undisclosed amount. With this acquisition, Philips aims to transform the health continuum along with the delivery of care with integrated solutions. The acquisition will offer the patient care management portfolio with cardiac diagnostics and monitoring. Biotelemetry Inc is a health technology company engaged in offering mHealth apps. Major players in the mHealth apps market are Omron Healthcare Inc., Johnson and Johnson, BioTelemetry Inc., Bristol-Myers Squibb Company, Qualcomm Technologies Inc., Diversinet Corp., Medtronic MiniMed, Agamatrix Inc., Apple Inc., Pfizer Inc., GlaxoSmithKline plc, Merck and Co. Inc., Novartis AG, Abbott Laboratories, AstraZeneca PLC., Sanofi, Ovia Health, Livongo Health, Orange, Sony, F. Hoffmann-La Roche Ltd., Allscripts, Jawbone Health Hub Inc., Boston Scientific Corporation, Withings S.A., iHealth Labs Inc., Nutrimedy, and Dr. Pad. North America was the largest region in the mHealth apps market in 2022. Asia-Pacific is expected to be the fastest-growing region in mHealth apps market. The regions covered in mHealth apps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the mHealth apps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The mHealth apps market includes revenues earned by entities by clinical and diagnostic apps, remote monitoring apps, productivity apps, reminder apps, text and video communication apps, prescription apps, and mental health apps. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global mhealth apps market is segmented - 1) By App Type: Disease And Treatment Management, Wellness Management, Other App Types 2) By Connected Medical Devices: Heart Rate Meters, Wearable Fitness Sensor Device, Blood Pressure Monitors, Pulse Oximeters, Other Connected Medical Devices 3) By Application: Monitoring Services, Fitness Solutions, Diagnostic Services, Treatment Services, Other Applications 4) By End-User: Physicians, Patients, Insurance Companies, Research Centers, Pharmacy, Biopharmaceutical Companies, Government, Tech Companies, Other End-Users

Healthcare fraud analytics refers to on-premise and on-demand analytical solutions that assist in identifying issues such as duplication/repetition of claims and errors in claim healthcare operations and applications. Healthcare fraud analytics aims to help healthcare companies to audit their accounts and find out fraudulent activities in various transactions. It identifies frauds related to billings, claims, prepayment, post payments, and payment integrity. The main type of solutions in healthcare fraud analytics are descriptive analytics, predictive analytics, prescriptive analytics. Descriptive analytics is a process of using current and historical data to identify trends and relationships. Healthcare fraud analytic solutions are deployed on-premise and on-demand, and they are widely used for insurance claims review, postpayment review, prepayment review, pharmacy billing misuse, payment integrity, other applications. Healthcare fraud analytics are used by public & government agencies, private insurance payers, third-party service providers. The healthcare fraud analytics market research report is one of a series of new reports from The Business Research Company that provides healthcare fraud analytics market statistics, including healthcare fraud analytics industry global market size, regional shares, competitors with a healthcare fraud analytics market share, detailed healthcare fraud analytics market segments, market trends and opportunities, and any further data you may need to thrive in the healthcare fraud analytics industry. This healthcare fraud analytics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global healthcare fraud analytics market size grew from $2.43 billion in 2022 to $3.09 billion in 2023 at a compound annual growth rate (CAGR) of 27.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The healthcare fraud analytics market size is expected to grow to $8 billion in 2027 at a CAGR of 26.9%. A large number of fraudulent activities in the healthcare sector contribute to the growth of the healthcare fraud analytics market. Medical providers, patients, and third parties who intentionally deceive the healthcare system into acquiring unlawful benefits can commit fraud based on deception or misrepresentation. These fraud and abuse involve kickbacks, billing, billing for services not provided, medical testing, and other fraudulent activities. For instance, according to Blue Cross Blue Shield Association, a US-based federation, in 2021, The National Heath Care Anti-Fraud Association estimated that health care fraud costs the nation about $68 billion annually, about 3 percent of the nation's $2.26 trillion in health care spending. Other estimates range as high as 10 percent of annual health care expenditure, or $230 billion. Thus, the increasing number of fraudulent activities in healthcare is contributing to the growth of the healthcare fraud market. Adopting and developing new technologies is a key trend gaining popularity in the healthcare fraud analytics market. The major companies are focusing on launching statistical data analytical and artificial intelligence (AI)-driven product and services to strengthen their market position. These fraud detection techniques perform various statistical operations, including data mining, regression analysis, machine learning, pattern recognition, supervised learning, unsupervised learning, and others. For instance, In December 2020, Codoxo, a US-based, AI-driven solution for healthcare, launched a healthcare integrity suite that gives health agencies unique insights and solutions for identifying risks and controlling costs in clinical care, network management, and payment integrity, provider education, and special investigative units. The suite includes fraud, provider, insight, network, clinical, and payment scope in its application. In June 2020, Sharecare, an Atlanta-based digital health company, acquired WhiteHatAI for an undisclosed amount. With this acquisition, Sharecare will integrate the WhiteHatAI, an AI-driven suite across portfolios that will help detect FWA before it occurs, improving healthcare organizations' efficiency and effectiveness. WhiteHatAI is a US-based healthcare AI company for healthcare payment integrity and fraud, waste, and abuse prevention. Major players in the healthcare fraud analytics market are International Business Machines Corporation (IBM), Optum, Inc., SAS Institute, Inc., Change Healthcare, EXL Service Holdings, Inc., Cotiviti, Wipro Limited, Conduent, Inc., Hindustan Computers Limited Technologies Limited, CGI Inc., DXC Technology Company, Northrop Grumman Corporation, LexisNexis Group, Pondera Solutions, WhiteHatAI, Healthcare Fraud Shield, FraudLens, FraudScope, HMS Holding Corp., Fair, Isaac and Company(FICO), Qlarant, Inc., Codoxo, H20.ai, and OSP Labs, Sharecare, Inc., North America was the largest region in the healthcare fraud analytics market in 2022. North America is expected to be the fastest-growing region in the forecast period. The regions covered in healthcare fraud analytics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the healthcare fraud analytics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The healthcare fraud analytics market includes revenues earned by entities by providing services such as fraud detection, predictive analytics, and Medicaid. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global healthcare fraud analytics market is segmented - 1) By Solution Type: Descriptive Analytics, Predictive Analytics, Prescriptive Analytics 2) By Delivery Model: On-Premise, On-Demand 3) By Application: Insurance Claims Review, Postpayment Review, Prepayment Review, Pharmacy Billing Misuse, Payment Integrity, Other Applications 4) By End User: Public & Government Agencies, Private Insurance Payers, Third-Party Service Providers

Hospital information systems refer to systems that collect, store, manage, and transmit patients' medical records. This system brings together all the information and processes of a hospital on a single platform. The hospital information systems are used to store and manage healthcare data. The main types of hospital information systems include clinical information systems, administrative information systems, electronic medical records, laboratory information systems, radiology information systems, pharmacy information systems, and others. The clinical information system refers to a computer-based system that is meant to gather, store, and alter clinical data on patients. These systems may be used at single locations or across entire healthcare systems. The various components include hardware, software, and services. These are deployed through web-based, on-premises, and cloud-based and are used in hospitals, insurance companies, and other end users. The hospital information systems market research report is one of a series of new reports from The Business Research Company that provides hospital information systems market statistics, including hospital information systems industry global market size, regional shares, competitors with a hospital information systems market share, detailed hospital information systems market segments, market trends and opportunities, and any further data you may need to thrive in the hospital information systems industry. This hospital information systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global hospital information system market size grew from $109.5 billion in 2022 to $119.22 billion in 2023 at a compound annual growth rate (CAGR) of 8.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The hospital information system market size is expected to grow to $173.59 billion in 2027 at a CAGR of 9.8%. Growing usage of digital healthcare infrastructure is expected to propel the growth of the hospital information systems market going forward. Digital healthcare infrastructure refers to digital technologies in the healthcare market aimed at providing better quality medical services such as real-time tracking of medical data using wearable medical devices. Using digital healthcare infrastructure in hospitals helps to improve patient monitoring in the hospitals. For instance, in September 2021, the government of India launched Ayushman Bharat, a central government digital mission program that aims to enhance and create a platform for the digital health ecosystem. This initiative helps to connect digital health solutions for hospitals across the country and bring a revolutionary change in the health facilities and infrastructure. Therefore, the growing usage of digital healthcare infrastructure is driving the growth of the hospital information systems market. Technological innovations are the key trend gaining popularity in the hospital information systems market. Major companies operating in the hospital information systems sector are focused on introducing technological innovations to sustain their position in the market. For instance, in April 2020, Google Cloud, a US-based company that provides cloud computing services for various sectors, launched Cloud Healthcare API. This is a cloud-based technology that helps in the exchange of medical data between health care applications that are built on Google Cloud. By using this cloud-based healthcare API users can store all the medical records in one place and can easily access the medical data. In January 2021, Philips Healthcare, a Netherlands-based company that provides laboratory information systems acquired Capsule Technologies. The acquisition is complimentary to Philips’ strategy to transform delivery of healthcare with integrated solutions. Capsule technologies is a US-based provider of medical device integration and data technologies for hospitals. Major players in the hospital information systems market are Cerner Corporation, Epic Systems, Mckesson Corporation, GE Healthcare, AllScripts, NextGen Healthcare, Philips Healthcare, Siemens Healthineers AG, Wipro Limited, Computer Programs and Systems Inc., OpenEMR, Agfa-Gevaert N.V., Eclipsys, and Koninklijke Philips NV. North America was the largest region in the hospital information systems market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hospital information systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the hospital information systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The hospital information system market consists of sales of medical practice management system, electronic health records (EHR), e-prescribing software, remote patient monitoring, master patient index (MPI), patient portal, urgent care applications, and medical billing software. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global hospital information system market is segmented - 1) By Components: Hardware, Software, Services 2) By Type: Clinical Information Systems, Administrative Information Systems, Electronic Medical Records, Laboratory Information System, Radiology Information System, Pharmacy Information System, Other Types 3) By Deployment: Web-Based, On-Premises, Cloud Based 4) By End-User: Hospitals, Insurance Companies, Other End Users

Pharmacy benefit management is a collection of businesses that function as intermediaries between insurance companies, pharmacies, and drug distributors. It is used to ensure that insurers and insurance companies pay reduced prescription costs by negotiating with pharmacists and medicine producers.   The main services of the pharmacy benefit management (PBM) are mail-delivery, specialty pharmacy, and preferred network pharmacy. Mail-delivery refers to mail order delivery that directly delivers the medicines to the desired location. These services are provided for different types of PBM. The different types of PBMs are commercial health plans, self-insured employer plans, medicare part D plans, and federal employees health benefits program. These different PBMs cater to major end-users which include pharmacy benefit management organization, mail order pharmacies, retail pharmacies, inpatient pharmacies, and outpatient pharmacies. The pharmacy benefit management market research report is one of a series of new reports from The Business Research Company that provides pharmacy benefit management market statistics, including pharmacy benefit management industry global market size, regional shares, competitors with a pharmacy benefit management market share, detailed pharmacy benefit management market segments, market trends and opportunities, and any further data you may need to thrive in the pharmacy benefit management industry. This pharmacy benefit management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global pharmacy benefit management market size grew from $541.32 billion in 2022 to $579.25 billion in 2023 at a compound annual growth rate (CAGR) of 7.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The pharmacy benefit management market size is expected to grow to $764.8 billion in 2027 at a CAGR of 7.2%. The rise in the number of people availing insurance significantly contributes to the growth of the pharmacy benefit management market. Insurance provides a solution to deal with the increased medical costs by covering the expenses related to treatment, hospitalization, health check-ups, and hospitalization expenses. Similarly, pharmacy benefit management (PBM) supports end-to-end healthcare products by combining medical as well as pharmaceutical products. This enables the insurers to have extensive information regarding the patients that helps the insurers provide efficient programs to patients. For instance, according to the India Brand Equity Foundation (IBEF), new premiums of life insurers registered 22.2% growth in September 2021, up 2.9% from September 2020. Therefore, the rise in the number of people availing of insurance is driving the growth of the pharmacy benefit management market. Strategic partnerships are a key trend in the pharmacy benefit management market. Strategic partnerships help the organizations enter into a new market and expand by leveraging each other's resources. In February 2021, Navitus Health Solutions, a US-based full-service pharmacy benefit management company, entered into a partnership with WithMe Health, Inc., a US-based contemporary pharmacy benefit manager (PBM) alternative that prioritizes people, results, and overall cost of care. This partnership gives Navitus access to WithMe Health's medication guidance capabilities, which will help employers and members get the most benefit from their medications by ensuring members are on the right medications and support to stay adherent, and responding to therapy. In January 2022, Centene, a US-based managed care company that provides healthcare solutions to families and individuals, acquired Magellan, a US-based pioneer in handling the health care industry's fastest-growing and most complicated sectors, including special populations, full pharmacy benefits, and other specialty areas, in a $2.2 billion deal. Through this acquisition, Centene will be able to provide whole-health, integrated healthcare solutions to complicated, high-cost populations, resulting in improved health outcomes at reduced costs. Major players in the pharmacy benefit management market are CVS Health, Cigna, OptumRx Inc., Anthem Inc., Centene Corporation, Abarca Health LLC, Medimpact, Express Scripts Holding Company, ProCare Rx, Aetna Inc., Magellan Health Inc., Prime Therapeutics LLC, SS&c Technologies, UnitedHealth Group, Rite Aid Corp, Benecard Services LLC, Rite Aid Corp and Benecard Services LL. North America was the largest region in the pharmacy benefit management market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharmacy benefit management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the pharmacy benefit management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The pharmacy benefit management market includes revenues earned by entities by providing case management, disease management, and drug utilization services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global pharmacy benefit management market is segmented - 1) By Services: Mail-Delivery, Specialty Pharmacy, Preferred Network Pharmacy 2) By Type: Commercial Health Plans, Self-Insured Employer Plans, Medicare Part D Plans, Federal Employees Health Benefits Program 3) By End User: Pharmacy Benefit Management Organization, Mail Order Pharmacies, Retail Pharmacies, Inpatient Pharmacies, Outpatient Pharmacies

The dispensing pharmacy packaging machine are used in preparing medications and nutraceuticals for secure distribution. Pharmacy packaging entails properly positioning the medications in order to preserve and keep their therapeutic efficacy. Packaging improves the product's overall appearance of quality and aids in permitting strong branding, which promotes the success of businesses. The main types of dispensing pharmacy packaging machines are fully automatic and semi-automatic. Fully Automatic is designating a system, device, or machine whose function is completely automatic. The speeds used is a low speed, standard speed, and high speed. The functions are filling, wrapping, mixing, and split, and other functions. The dispensing pharmacy packaging machine market research report is one of a series of new reports from The Business Research Company that provides dispensing pharmacy packaging machine market statistics, including dispensing pharmacy packaging machine industry global market size, regional shares, competitors with a dispensing pharmacy packaging machine market share, detailed dispensing pharmacy packaging machine market segments, market trends and opportunities, and any further data you may need to thrive in the dispensing pharmacy packaging machine industry. This dispensing pharmacy packaging machine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global dispensing pharmacy packaging machine market size grew from $1.87 billion in 2022 to $2.03 billion in 2023 at a compound annual growth rate (CAGR) of 8.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, causing inflation across goods and services and affecting many markets across the globe. The dispensing pharmacy packaging machine market size is expected to grow to $2.81 billion in 2027 at a CAGR of 8.5%. The rising growth of biopharma is expected to propel the growth of the dispensing pharmacy packaging going forward. Biopharma refers to medical drugs produced using biotechnology. Pharmaceutical packaging machinery provides efficient solutions for preparing pharmaceutical and nutraceutical products for distribution. For instance, according to HCP detection, an International organizational website for detecting host cell proteins data, The global biopharmaceuticals are increasing, and the forecast for 2023 is estimated to reach USD 341.16 billion. Therefore, the rising growth of biopharma is driving the dispensing pharmacy packaging machine market. Technological advancements are a key trend gaining popularity in dispensing pharmacy packaging machines market. Major companies operating in dispensing pharmacy packaging machines to strengthen their position in the market. For instance, in October 2021, ATS packaging machinery, an Italy-based company operating in dispensing pharmacy packaging machines market launched a new Gemini capping machine. This new machine has been developed with Siemens machine control technology and includes features such as providing preventative maintenance and remote diagnostics and service support and is suitable across a wide range of industrial applications including pharmaceuticals. It is also suitable for dispensing pumps that work with maximum flexibility. In July 2022, BD, a US-based medical technology company acquired Parata Systems for an undisclosed amount. This acquisition of Parata systems builds on BD's legacy and experience of seamlessly integrating teams to drive future growth and innovation. Parata Systems is a US-based company operating in dispensing pharmacy packaging machines. Major players in the dispensing pharmacy packaging machine market are TOSHO Corporation, JVM, Yuyama Manufacturing Co Ltd., Canon Lifecare Solutions Inc., Takazono Corporation, Nisshin Medical Device Co Ltd., Yung Chung Machinery Co, Heqian Industry  Co, Swisslog Healthcare, Futain Industry Trading Co, MTS Medication Technologies, Robotik Technology, Talyst, Bausch+Strobel and Robert Bosch GmbH. Asia-Pacific was the largest region in the dispensing pharmacy packaging market in 2022. The regions covered in the dispensing pharmacy packaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the dispensing pharmacy packaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The dispensing pharmacy packaging machine market consists of sales of pharmaceutical sachets, polybags, and blister packs. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global dispensing pharmacy packaging machine market is segmented - 1) By Product Type: Fully Automatic, Semi-Automatic 2) By Speed: Low Speed, Standard Speed, High Speed 3) By Function: Filling, Wrapping, Mixing And Split, Other Functions